Taken together, these expression datasets from neuroblastoma patient samples and cell lines point toward a major role of P‐gp specifically in neuroblastoma resistance at relapse, while the ERBB family appears to play a minor role. The gene discussed is EGFR; the disease is neuroblastoma.